Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

General Pharmaceutical Council sign

All provisionally registered trainees must be risk-assessed before starting work, regulator says

All preregistration pharmacists on the provisional register must be risk-assessed by their employer before they can start work, the General Pharmaceutical Council has said.

Abbot laboratories

Approved COVID-19 antibody test 'not intended for home use', manufacturer warns

A Public Health England-approved COVID-19 antibody test that was being sold for use at home with a finger-prick blood test is not intended to be used in this way, the manufacturer has said.

Video consultation

Video consultation system could be offered to all Scottish community pharmaciesSubscription

Community pharmacists in Scotland have begun trialling the ‘NHS Near Me’ video consultation service, and talks have taken place with the Scottish government on how the system could be deployed across community pharmacy.

Superdrug antibody test kit for COVID 19

Pharmacies selected as a ‘target setting’ for COVID-19 antibody testing

Pharmacies have been listed as a “target setting” for COVID-19 antibody tests under specifications published by the Medicines and Healthcare products Regulatory Agency.

Remdesivir bottles

Remdesivir could be granted conditional marketing authorisation 'in the coming days', says EMA

The investigational antiviral medicine, remdesivir, may be granted a conditional marketing authorisation as a treatment for COVID-19 “in the coming days”, the head of the European Medicines Agency has said.

More news

Patient in critical care in hospital

Corticosteroids should be used with caution in patients with COVID-19, researchers say

The use of corticosteroids in coronavirus infections is associated with increased risk of death and side effects, such as bacterial infections and hypokalaemia, researchers have said.

Chinese woman having blood pressure taken

Renin-angiotensin system inhibitors not linked to COVID-19 severity, researchers conclude

Among people with hypertension, the severity of COVID-19 is not associated with the use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, data from Wuhan, China, suggest.

MDT meeting

Daily multidisciplinary team meetings could cut COPD hospital staysSubscription

Daily multidisciplinary team (MDT) meetings significantly reduced the length of hospital stay for patients with COPD, a study published in the Journal of the American Osteopathic Association has found.

Apixaban may be more effective and safer than rivaroxaban research suggests

Apixaban may be more effective and safer than rivaroxaban, research suggestsSubscription

Adults with non-valvular atrial fibrillation prescribed apixaban have a lower rate of ischaemic stroke and systemic blood clots compared with those prescribed rivaroxaban, according to a retrospective cohort study in Annals of Internal Medicine.

Neurological symptoms common in COVID-19 patients researchers say

Neurological symptoms common in COVID-19 patients, researchers say

Neurological symptoms are common in patients with COVID-19, particularly if they have a severe infection, research published in JAMA Neurology suggests.

More research briefings

Sick man on subway wearing mask

Everything you should know about the coronavirus outbreak

The latest information about the novel coronavirus identified in Wuhan, China, and advice on how pharmacists can help concerned patients and the public.

Isolated older woman at home

Isolated, but not alone: how pharmacies are supporting older patients during COVID-19

Community pharmacy is providing a vital connection to support older and clinically vulnerable patients during lockdown in the UK.

Members of the Royal Pharmaceutical Society from around the world explain how their practice has changed in the face of COVID-19

How RPS members around the world are responding to the COVID-19 pandemic

Members of the Royal Pharmaceutical Society from around the world explain how their practice has changed in the face of COVID-19.

Jatinder Harchowal

Pharmacy — one of the driving forces behind the COVID-19 emergency hospitals

The temporary field hospitals set up across the UK to help the NHS cope during the COVID-19 pandemic have given hospital pharmacists a unique opportunity for valuable learning and teamwork.

More features

Virus lifecycle and potential therapies

Targeting COVID-19: the drugs being fast-tracked through clinical trials and how they work

The NHS is rapidly enrolling patients into studies as part of a focused international effort to find medicines that will interfere with viral replication or help modulate the immune system response.

More infographics